Genotoxic properties of cyclopentenone prostaglandins and the onset of glutathione depletion

Chemical Research in Toxicology

Volumn 26, Issue 2, 2013, Pages 252-261

  Solecki, Gergely Morten ^a   Groh, Isabel Anna Maria ^a   Kajzar, Julia ^a   Haushofer, Carolin ^a   Scherhag, Anne ^a   Schrenk, Dieter ^a   Esselen, Melanie ^a  

^a France   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CYCLOPENTENONE; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; GLUTATHIONE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PROSTAGLANDIN; PROSTAGLANDIN A2; PROSTAGLANDIN B2; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CENTROMERE; CHEMICAL STRUCTURE; CHRONIC INFLAMMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME ASSAY; GENOTOXICITY; HAMSTER; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MALE; MICRONUCLEUS; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; TOXICITY TESTING;

ANIMALS; CELL LINE; CRICETINAE; CYCLOPENTANES; DNA BREAKS; FIBROBLASTS; GLUTATHIONE; MUTAGENS; OXIDATIVE STRESS; PROSTAGLANDINS;

EID: 84874075597     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx300435p     Document Type: Article

References (59)

1. Straus, D. S. and Glass, C. K. (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets Med. Res. Rev. 21, 185-210 (Pubitemid 32303994)
2. Funk, C. D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294, 1871-1875 (Pubitemid 33101574)
3. Pérez-Sala, D., Cernuda-Morollón, E., and Cañada, F. J. (2003) Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2 J. Biol. Chem. 278, 51251-51260 (Pubitemid 38020362)
4. Grau, R., Iñiguez, M. A., and Fresno, M. (2004) Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator- activated receptor-gamma-independent mechanism Cancer Res. 64, 5162-5171 (Pubitemid 39006534)
5. Ciucci, A., Gianferretti, P., Piva, R., Guyot, T., Snape, T. J., Roberts, S. M., and Santoro, M. G. (2006) Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway Mol. Pharmacol. 70, 1812-1821
6. Cernuda-Morollón, E., Pineda-Molina, E., Cañada, F. J., and Pérez-Sala, D. (2001) 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit J. Biol. Chem. 276, 35530-35536
7. Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., and Yamamoto, M. (2004) Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-D12,14-prostaglandin J2 Mol. Cell. Biol. 24, 36-45 (Pubitemid 38010033)
8. Shibata, T., Yamada, T., Ishii, T., Kumazawa, S., Nakamura, H., Masutani, H., Yodoi, J., and Uchida, K. (2003) Thioredoxin as a molecular target of cyclopentenone prostaglandins J. Biol. Chem. 278, 26046-26054 (Pubitemid 36835372)
9. Bogaards, J. J., Venekamp, J. C., and van Bladeren, P. J. (1997) Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1 Chem. Res. Toxicol. 10, 310-317 (Pubitemid 27137142)
10. Stamatakis, K., Sánchez-Gómez, F. J., and Pérez-Sala, D. (2006) Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton J. Am. Soc. Nephrol. 17, 89-98
11. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation Cell 83, 813-819 (Pubitemid 3006325)
12. Shiraki, T., Kamiya, N., Shiki, S., Kodama, T. S., Kakizuka, A., and Jingami, H. (2005) Alpha, beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma J. Biol. Chem. 280, 14145-14153 (Pubitemid 40517317)
13. Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., and Santoro, M. G. (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase Nature 403, 103-108 (Pubitemid 30038530)
14. Wang, J. J. and Mak, O. T. (2011) Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells Prostaglandins Other Lipid Mediators 94, 104-111
15. Rosetti, M., Frasnelli, M., Fabbri, F., Arienti, C., Vannini, I., Tesei, A., Zoli, W., and Conti, M. (2008) Pro-apoptotic activity of cyclopentenone in cancer cells Anticancer Res. 28, 315-320 (Pubitemid 351362919)
16. Kawamoto, Y., Nakamura, Y., Naito, Y., Torii, Y., Kumagai, T., Osawa, T., Ohigashi, H., Satoh, K., Imagawa, M., and Uchida, K. (2000) Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes. 15-deoxy-delta(12,14)-prostaglandin j2-induced expression of glutathione S-transferases J. Biol. Chem. 275, 11291-11299 (Pubitemid 30212777)
17. Oh, J. Y., Giles, N., Landar, A., and Darley-Usmar, V. (2008) Accumulation of 15-deoxy-delta (12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction Biochem. J. 411, 297-306 (Pubitemid 351580182)
18. Grivennikov, S. I., Greten, F. R., and Karin, M. (2010) Immunity, inflammation, and cancer Cell 140, 883-899
19. Mantovani, A. (2010) Molecular pathways linking inflammation and cancer Curr. Mol. Med. 10, 369-373
20. Chinery, R., Coffey, R. J., Graves-Deal, R., Kirkland, S. C., Sanchez, S. C., Zackert, W. E., Oates, J. A., and Morrow, J. D. (1999) Prostaglandin J2 and 15-deoxy-D12,14-prostaglandin J2 induce proliferation of cyclooxygenase- depleted colorectal cancer cells Cancer Res. 59, 2739-2746 (Pubitemid 29269124)
21. Millán, O., Rico, D., Peinado, H., Zarich, N., Stamatakis, K., Pérez-Sala, D., Rojas, J. M., Cano, A., and Boscá, L. (2006) Potentiation of tumor formation by topical administration of 15-deoxy-D12,14-prostaglandin J2 in a model of skin carcinogenesis Carcinogenesis 27, 328-336 (Pubitemid 43159887)
22. Dickinson, D. A. and Forman, H. J. (2002) Glutathione in defense and signaling: lessons from a small thiol Ann. N.Y. Acad. Sci. 973, 488-504 (Pubitemid 36131049)
23. Ortega, A. L., Mena, S., and Estrela, J. M. (2011) Glutathione in Cancer Cell Death Cancers 3, 1285-1310
24. Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J. C., and Sasaki, Y. F. (2000) Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing Environ. Mol. Mutagen. 35, 206-221 (Pubitemid 30196665)
25. Tietze, F. (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathion: Application to mammalian blood and other tissues Anal. Biochem. 27, 502-522
26. Groh, I. A., Cartus, A. T., Vallicotti, S., Kajzar, J., Merz, K. H., Schrenk, D., and Esselen, M. (2012) Genotoxic potential of methyleugenol and selected methyleugenol metabolites in cultured Chinese hamster V79 cells Food Funct. 3, 428-436
27. Pelka, J., Gehrke, H., Esselen, M., Türk, M., Crone, M., Bräse, S., Muller, T., Blank, H., Send, W., Zibat, V., Brenner, P., Schneider, R., Gerthsen, D., and Marko, D. (2009) Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity Chem. Res. Toxicol. 22, 649-659
28. Santoro, M. G. (1997) Antiviral activity of cyclopentenone prostanoids Trends Microbiol. 5, 276-281 (Pubitemid 27314516)
29. Kansanen, E., Kivelä, A. M., and Levonen, A. L. (2009) Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2 Free Radical Biol. Med. 47, 1310-1317
30. Suzuki, K., Shono, F., and Uyeda, M. (1998) Inhibition of topoisomerases by antitumor prostaglandins Biosci. Biotechnol. Biochem. 62, 2073-2075 (Pubitemid 128473773)
31. Suzuki, K. and Uyeda, M. (2002) Inhibitory properties of antitumor prostaglandins against topoisomerases Biosci. Biotechnol. Biochem. 66, 1706-12 (Pubitemid 39246829)
32. Coste, F., Ober, M., Carell, T., Boiteux, S., Zelwer, C., and Castaing, B. (2004) Structural basis for the recognition of the FapydG lesion (2,6-Diamino-4-hydroxy-5-formamidopyrimidine) by formamidopyrimidine-DNA glycosylase J. Biol. Chem. 279, 44074-44083 (Pubitemid 39390717)
33. Zharkov, D. O., Ishchenko, A. A., Douglas, K. T., and Nevinsky, G. A. (2003) Recognition of damaged DNA by Escherichia coli FPG protein: Insights from structural and kinetic data Mutat. Res. 531, 141-156 (Pubitemid 37456728)
34. Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., and Loguercio, C. (2007) Chronic inflammation and oxidative stress in human carcinogenesis Int. J. Cancer. 121, 2381-2386 (Pubitemid 350022406)
35. Balendiran, G. K., Dabur, R., and Fraser, D. (2004) The role of glutathione in cancer Cell Biochem. Funct. 22, 343-352 (Pubitemid 39518098)
36. Kensler, T. W., Wakabayashi, N., and Biswal, S. (2007) Cell survival responses to environmental stresses via the keap1-nrf2-are pathway Annu. Rev. Pharmacol. Toxicol. 47, 89-116
37. Ray, D. M., Akbiyik, F., and Phipps, R. P. (2006) The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-delta 12, 14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms J. Immunol. 177, 5068-5076 (Pubitemid 44527577)
38. Brunoldi, E. M., Zanoni, G., Vidari, G., Sasi, S., Freeman, M. L., Milne, G. L., and Morrow, J. D. (2007) Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione Chem. Res. Toxicol. 20, 1528-35 (Pubitemid 350057223)
39. van Iersel, M. L., Cnubben, N. H., Smink, N., Koeman, J. H., and van Bladeren, P. J. (1999) Interactions of prostaglandin A2 with the glutathione-mediated biotransformation system Biochem. Pharmacol. 57, 1383-1390 (Pubitemid 29225101)
40. Paumi, C. M., Wright, M., Townsend, A. J., and Morrow, C. S. (2003) Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15- deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells Biochemistry 42, 5429-5437 (Pubitemid 36560440)
41. Brechbuhl, H. M., Min, E., Kariya, C., Frederick, B., Raben, D., and Day, B. J. (2009) Select cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transport Free Radical Biol. Med. 47, 722-730
42. Song, N. Y., Kim, D. H., Kim, E. H., Na, H. K., Kim, N. J., Suh, Y. G., and Surh, Y. J. (2011) Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells Chem. Res. Toxicol. 24, 1231-1241
43. Lee, T. S., Tsai, H. L., and Chau, L. Y. (2003) Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2 J. Biol. Chem. 278, 19325-19330
44. Kim, J. W., Li, M. H., Jang, J. H., Na, H. K., Song, N. Y., Lee, C., Johnson, J. A., and Surh, Y. J. (2008) 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2 Biochem. Pharmacol. 76, 1577-1589
45. Lim, H. J., Lee, K. S., Lee, S., Park, J. H., Choi, H. E., Go, S. H., Kwak, H. J., and Park, H. Y. (2007) 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells Toxicol. Appl. Pharmacol. 223, 20-27 (Pubitemid 47211263)
46. Levonen, A. L., Dickinson, D. A., Moellering, D. R., Mulcahy, R. T., Forman, H. J., and Darley-Usmar, V. M. (2001) Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells Arterioscler., Thromb., Vasc. Biol. 21, 1846-1851 (Pubitemid 34219791)
47. Zacharaki, P., Stephanou, G., and Demopoulos, N. A. (2012) Comparison of the aneugenic properties of nocodazole, paclitaxel and griseofulvin in vitro. Centrosome defects and alterations in protein expression profiles J. Appl. Toxicol. 10.1002/jat.2745
48. Decordier, I., Cundari, E., and Kirsch-Volders, M. (2008) Survival of aneuploid, micronucleated and/or polyploid cells: crosstalk between ploidy control and apoptosis Mutat. Res. 651, 30-39
49. Armstrong, J. S., Steinauer, K. K., Hornung, B., Irish, J. M., Lecane, P., Birrell, G. W., Peehl, D. M., and Knox, S. J. (2002) Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human b lymphoma cell line Cell Death Differ. 9, 252-263 (Pubitemid 34223869)
50. Tormos, C., Javier Chaves, F., Garcia, M. J., Garrido, F., Jover, R., O'Connor, J. E., Iradi, A., Oltra, A., Oliva, M. R., and Saez, G. T. (2004) Role of glutathione in the induction of apoptosis and c-fos and c-jun mrnas by oxidative stress in tumor cells Cancer Lett. 208, 103-113 (Pubitemid 38501790)
51. Combes, R. D., Stopper, H., and Caspary, W. J. (1995) The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals Mutagenesis 10, 403-408
52. Gille, J. J., van Berkel, C. G., and Joenje, H. (1994) Mutagenicity of metabolic oxygen radicals in mammalian cell cultures Carcinogenesis 15, 2695-2699
53. Oller, A. R. and Thilly, W. G. (1992) Mutational spectra in human B-cells. Spontaneous, oxygen and hydrogen peroxide-induced mutations at the hprt gene J. Mol. Biol. 228, 813-826 (Pubitemid 23017272)
54. 2-isoprostanes) in vivo J. Lipid Res. 52, 113-124
55. Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., and Uchida, K. (2002) 15-Deoxy-Δ -prostaglandin J. A prostaglandin D metabolite generated during inflammatory processes J. Biol. Chem. 277, 10459-10466 (Pubitemid 34968167)
56. 2 Proc. Natl. Acad. Sci. U.S.A. 104, 20979-20984
57. Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., and Willoughby, D. A. (1999) Inducible cyclooxygenase may have anti-inflammatory properties Nat. Med. 5, 698-701 (Pubitemid 29289435)
58. Blanco, M., Moro, M. A., Davalos, A., Leira, R., Castellanos, M., Serena, J., Vivancos, J., Rodríguez-Yáñez, M., Lizasoain, I., and Castillo, J. (2005) Increased plasma levels of 15-deoxy D prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke Stroke 36, 1189-1194 (Pubitemid 40798737)
59. Comabella, M., Pradillo, J. M., Fernandez, M., Rio, J., Lizasoain, I., Julia, E., Moro, M. A., Sastre-Garriga, J., and Montalban, X. (2009) Plasma levels of 15d-PGJ2 are not altered in multiple sclerosis Eur. J. Neurol. 16, 1197-1201